Massmutual Trust CO Fsb Bristol Myers Squibb CO Transaction History

Massmutual Trust CO Fsb

  • $3.4 Billion
  • Q1 2025

A detailed history of Massmutual Trust CO Fsb transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 10,031 shares of BMY stock, worth $611,790. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,031
Previous 8,687 15.47%
Holding current value
$611,790
Previous $491,000 24.44%
% of portfolio
0.02%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 01, 2025
BUY
$53.9 - $63.11 $72,441 - $84,819
1,344 Added 15.47%
10,031 $611,000
Q4 2024

Jan 16, 2025
BUY
$51.92 - $59.94 $17,237 - $19,900
332 Added 3.97%
8,687 $491,000
Q3 2024

Oct 02, 2024
BUY
$39.66 - $51.75 $75,671 - $98,739
1,908 Added 29.6%
8,355 $432,000
Q2 2024

Jul 02, 2024
BUY
$40.25 - $52.99 $9,096 - $11,975
226 Added 3.63%
6,447 $267,000
Q1 2024

Apr 09, 2024
BUY
$47.98 - $54.4 $11,515 - $13,056
240 Added 4.01%
6,221 $337,000
Q4 2023

Jan 03, 2024
SELL
$48.48 - $57.85 $2.9 Million - $3.45 Million
-59,721 Reduced 90.9%
5,981 $306,000
Q3 2023

Oct 03, 2023
SELL
$57.89 - $64.73 $69,989 - $78,258
-1,209 Reduced 1.81%
65,702 $3.81 Million
Q2 2023

Aug 01, 2023
BUY
$63.71 - $70.74 $3.52 Million - $3.91 Million
55,300 Added 476.27%
66,911 $4.28 Million
Q1 2023

Apr 11, 2023
SELL
$65.71 - $74.53 $24,772 - $28,097
-377 Reduced 3.14%
11,611 $804,000
Q4 2022

Jan 06, 2023
BUY
$68.48 - $81.09 $23,557 - $27,894
344 Added 2.95%
11,988 $863,000
Q3 2022

Oct 07, 2022
SELL
$0.13 - $76.84 $262 - $155,216
-2,020 Reduced 14.78%
11,644 $828,000
Q2 2022

Jul 07, 2022
SELL
$72.62 - $79.98 $72,256 - $79,580
-995 Reduced 6.79%
13,664 $1.05 Million
Q1 2022

Apr 08, 2022
SELL
$61.48 - $73.72 $36,088 - $43,273
-587 Reduced 3.85%
14,659 $1.07 Million
Q4 2021

Feb 09, 2022
SELL
$53.63 - $62.52 $71,649 - $83,526
-1,336 Reduced 8.06%
15,246 $951,000
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $82,897 - $97,103
1,401 Added 9.23%
16,582 $981,000
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $681 - $741
11 Added 0.07%
15,181 $1.01 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $50,676 - $56,995
-854 Reduced 5.33%
15,170 $958,000
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $12,067 - $13,674
209 Added 1.32%
16,024 $994,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $9,877 - $10,946
-172 Reduced 1.08%
15,815 $953,000
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $18,912 - $22,111
-345 Reduced 2.11%
15,987 $940,000
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $57,582 - $83,680
-1,241 Reduced 7.06%
16,332 $910,000
Q4 2019

May 15, 2020
BUY
$49.21 - $64.19 $131,685 - $171,772
2,676 Added 17.96%
17,573 $1.13 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $507,979 - $602,282
11,877 Added 393.28%
14,897 $755,000
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $29,493 - $32,613
-661 Reduced 17.96%
3,020 $137,000
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $31,809 - $37,929
-705 Reduced 16.07%
3,681 $176 Million
Q4 2018

Feb 26, 2019
SELL
$48.76 - $63.23 $21,942 - $28,453
-450 Reduced 9.31%
4,386 $228 Million
Q3 2018

Nov 09, 2018
SELL
$55.19 - $62.25 $14,901 - $16,807
-270 Reduced 5.29%
4,836 $300 Million
Q2 2018

Aug 20, 2018
BUY
$50.53 - $62.98 $1,313 - $1,637
26 Added 0.51%
5,106 $283 Million
Q1 2018

May 21, 2018
SELL
$59.92 - $68.98 $134,879 - $155,273
-2,251 Reduced 30.71%
5,080 $321 Million
Q4 2017

Mar 01, 2018
SELL
$59.94 - $65.35 $59,580 - $64,957
-994 Reduced 11.94%
7,331 $449 Million
Q4 2017

Feb 21, 2018
BUY
$59.94 - $65.35 $119 - $130
2 Added 0.02%
8,325 $1.3 Billion
Q3 2017

Feb 13, 2018
SELL
$55.23 - $63.74 $40,980 - $47,295
-742 Reduced 8.19%
8,323 $531 Million
Q2 2017

Aug 14, 2017
BUY
N/A
9,065
9,065 $505 Million

Others Institutions Holding BMY

# of Institutions
2,772
Shares Held
1.56B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $130B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email